ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Jade Biosciences
14.00
-0.3900
-2.71%
盘后:
14.00
0.0000
0.00%
16:10 EDT
成交量:
135.56万
成交额:
1,897.35万
市值:
8.90亿
市盈率:
-5.97
高:
14.45
开:
14.33
低:
13.82
收:
14.39
52周最高:
28.00
52周最低:
8.36
股本:
6,359.74万
流通股本:
4,712.20万
量比:
1.52
换手率:
2.88%
股息:
- -
股息率:
- -
每股收益(TTM):
-2.3433
每股收益(LYR):
-3.1931
净资产收益率:
-89.18%
总资产收益率:
-33.59%
市净率:
0.31
市盈率(LYR):
-4.38
数据加载中...
总览
公司
新闻资讯
公告
Jade Biosciences:Jade301在灵长类动物中展现约25天半衰期及可预测的肌肉分布
美股速递
·
09/30
Jade Biosciences:Jade301展现高亲和力、选择性IFN-β结合能力,效力优于Dazukibart
美股速递
·
09/30
Jade Biosciences在EADV 2026公布Jade301临床前数据,一款潜在同类最佳的半衰期延长型抗IFN-β单克隆抗体用于皮肌炎治疗
美股速递
·
09/30
美国研究综述-卡迪纳尔健康、卢门图姆控股、公共仓储
路透中文
·
08/12
Jade Biosciences 与 Paragon Therapeutics 达成全球独家授权协议 - 美国证券交易委员会文件披露
投资观察
·
07/07
Jade Biosciences - 美国证监会文件披露,Paragon被禁止针对许可靶点开展新项目至少五年
美股速递
·
07/02
Jade Biosciences与Paragon达成协议:按授权产品净销售额支付低至中个位数百分比特许权使用费
美股速递
·
07/02
Jade Biosciences 与 Paragon Therapeutics 签署全球独家许可协议 - SEC 文件披露
美股速递
·
07/02
新闻稿:Jade Biosciences宣布任命Mark Eisner医学博士、公共卫生硕士加入董事会
投资观察
·
06/26
热门话题-Jade Biosciences因计划中的股权融资而股价下跌
路透中文
·
06/04
Jade Biosciences宣布首例受试者接受Jade201首次人体I期临床试验给药
美股速递
·
05/27
Jade Biosciences宣布首位受试者接受Jade101治疗IgA肾病的二期Juniper临床试验给药
美股速递
·
05/26
美国研究综述-爱彼迎、HII、特斯拉
路透中文
·
05/11
Jade Biosciences注册声明:售股股东拟转售最多3954.2339万股普通股——美国证监会文件披露
美股速递
·
05/08
玉生物科学任命爱德华·R·康纳博士为首席医疗官
投资观察
·
04/22
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/JBIO/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","market":"US","secType":"STK","nameCN":"Jade Biosciences","latestPrice":14,"timestamp":1791835200000,"preClose":14.39,"halted":0,"volume":1355585,"hourTrading":{"tag":"盘后","latestPrice":14,"preClose":14,"latestTime":"16:10 EDT","volume":6489,"amount":90846,"timestamp":1791835804477,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02710215427380129,"floatShares":47122000,"shares":63597387,"eps":-2.343303,"marketStatus":"盘后交易","change":-0.39,"latestTime":"10-12 18:42:37 EDT","open":14.33,"high":14.445,"low":13.82,"amount":18973508,"amplitude":0.043433,"askPrice":18.34,"askSize":100,"bidPrice":10,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-2.343303,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791849600000},"marketStatusCode":4,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":14.39,"preHourTrading":{"tag":"盘前","latestPrice":14.33,"preClose":14.39,"latestTime":"09:13 EDT","volume":4,"amount":55.33,"timestamp":1791810781379,"change":-0.06,"changeRate":-0.00417,"amplitude":0.092425},"postHourTrading":{"tag":"盘后","latestPrice":14,"preClose":14,"latestTime":"16:10 EDT","volume":6489,"amount":90846,"timestamp":1791835804477,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.521407,"impliedVol":1.6276,"impliedVolPercentile":0.9721},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","floatShares":47122000,"roa":"-33.59%","roe":"-89.18%","lyrEps":-3.193116,"volumeRatio":1.521407,"shares":63597387,"dividePrice":0,"high":14.445,"amplitude":0.043433,"preClose":14.39,"low":13.82,"week52Low":8.36,"pbRate":"0.31","week52High":28,"institutionHeld":0,"latestPrice":14,"committee":-0.904762,"eps":-2.343303,"divideRate":0,"volume":1355585,"delay":0,"ttmEps":-2.343303,"open":14.33,"prevYearClose":15.43,"prevWeekClose":14.39,"prevMonthClose":14.05,"prevQuarterClose":14.05,"fiveDayClose":14.07,"twentyDayClose":18.18,"sixtyDayClose":20.86,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.15429122468659595},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"JBIO","fiscalQuarterEnding":"2026/06","expectedEps":-0.66,"name":null,"time":"盘前","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.76},{"market":"US","date":"2026-05-07","symbol":"JBIO","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"盘后","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2026-03-06","symbol":"JBIO","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"盘前","type":"earning","dateTimestamp":1772773200000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2025-11-13","symbol":"JBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.57,"name":null,"time":"盘后","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2025-08-13","symbol":"JBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.43,"name":null,"time":"盘后","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JBIO\",market:\"US\",,,undefined,":[{"executeDate":"2025-04-29","recordDate":"2025-04-25","paymentDate":"2025-04-28","value":2.4,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5455,"buy":0.4545,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5455,"analysts":11,"updateTime":1781668800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JBIO","date":"2026-10-09","current":-5.974473,"percent":0.553672,"low":-10.392766,"twenty":-8.733055,"median":-6.276995,"eighty":-2.889581,"high":-2.319279,"avg":-5.942336,"sd":2.608029,"marketCap":899903026},"quantilePoints":[{"date":"2025-05-16","current":-2.4743,"twenty":-2.881556,"median":-2.868851,"eighty":-2.514424,"marketCap":232480279},{"date":"2025-05-23","current":-2.511409,"twenty":-2.870857,"median":-2.517932,"eighty":-2.47965,"marketCap":235966978},{"date":"2025-05-30","current":-2.432499,"twenty":-2.695315,"median":-2.507901,"eighty":-2.466944,"marketCap":228552715},{"date":"2025-06-06","current":-2.363881,"twenty":-2.548988,"median":-2.487393,"eighty":-2.464507,"marketCap":222105530},{"date":"2025-06-13","current":-2.381035,"twenty":-2.548988,"median":-2.48419,"eighty":-2.428382,"marketCap":223717326},{"date":"2025-06-20","current":-3.228464,"twenty":-2.618978,"median":-2.48419,"eighty":-2.41603,"marketCap":303340063},{"date":"2025-06-27","current":-3.17357,"twenty":-2.886906,"median":-2.487393,"eighty":-2.426323,"marketCap":298182315},{"date":"2025-07-03","current":-3.822008,"twenty":-3.217485,"median":-2.511409,"eighty":-2.437181,"marketCap":359108215},{"date":"2025-07-11","current":-3.609293,"twenty":-3.553713,"median":-2.554094,"eighty":-2.45809,"marketCap":339121941},{"date":"2025-07-18","current":-3.262773,"twenty":-3.420594,"median":-2.844205,"eighty":-2.467494,"marketCap":306563656},{"date":"2025-07-25","current":-2.857929,"twenty":-3.391775,"median":-2.873866,"eighty":-2.470924,"marketCap":268525263},{"date":"2025-08-01","current":-2.466808,"twenty":-3.382854,"median":-2.844205,"eighty":-2.467494,"marketCap":231776307},{"date":"2025-08-08","current":-2.511409,"twenty":-3.347859,"median":-2.705254,"eighty":-2.467494,"marketCap":235966978},{"date":"2025-08-15","current":-2.350869,"twenty":-3.260028,"median":-2.645214,"eighty":-2.467494,"marketCap":220882962},{"date":"2025-08-22","current":-2.56269,"twenty":-3.244933,"median":-2.581542,"eighty":-2.467494,"marketCap":240785267},{"date":"2025-08-29","current":-2.805764,"twenty":-3.217485,"median":-2.645214,"eighty":-2.470924,"marketCap":263623978},{"date":"2025-09-05","current":-2.70159,"twenty":-3.17357,"median":-2.64603,"eighty":-2.473669,"marketCap":253835959},{"date":"2025-09-12","current":-2.694645,"twenty":-3.152985,"median":-2.64603,"eighty":-2.4743,"marketCap":253183424},{"date":"2025-09-19","current":-2.677282,"twenty":-3.087798,"median":-2.64603,"eighty":-2.473669,"marketCap":251552088},{"date":"2025-09-26","current":-2.798819,"twenty":-3.080936,"median":-2.64603,"eighty":-2.4743,"marketCap":262971443},{"date":"2025-10-03","current":-2.892576,"twenty":-3.080936,"median":-2.67381,"eighty":-2.479351,"marketCap":271780660},{"date":"2025-10-10","current":-3.264131,"twenty":-3.152985,"median":-2.690514,"eighty":-2.480987,"marketCap":306691262},{"date":"2025-10-17","current":-3.397822,"twenty":-3.16343,"median":-2.70159,"eighty":-2.487393,"marketCap":319252553},{"date":"2025-10-24","current":-3.448173,"twenty":-3.228464,"median":-2.743259,"eighty":-2.487393,"marketCap":323983428},{"date":"2025-10-31","current":-3.420393,"twenty":-3.264131,"median":-2.760622,"eighty":-2.487393,"marketCap":321373290},{"date":"2025-11-07","current":-3.10787,"twenty":-3.295384,"median":-2.802291,"eighty":-2.501116,"marketCap":292009233},{"date":"2025-11-14","current":-3.361361,"twenty":-3.350943,"median":-2.840774,"eighty":-2.504393,"marketCap":315826746},{"date":"2025-11-21","current":-5.620897,"twenty":-3.393147,"median":-2.85789,"eighty":-2.511409,"marketCap":528128273},{"date":"2025-11-28","current":-6.276995,"twenty":-3.403031,"median":-2.873866,"eighty":-2.511409,"marketCap":589773908},{"date":"2025-12-05","current":-6.071353,"twenty":-3.439839,"median":-2.892576,"eighty":-2.514154,"marketCap":570452142},{"date":"2025-12-12","current":-7.266038,"twenty":-3.474564,"median":-2.963052,"eighty":-2.522532,"marketCap":682702402},{"date":"2025-12-19","current":-8.108193,"twenty":-3.595569,"median":-2.993278,"eighty":-2.527742,"marketCap":761829634},{"date":"2025-12-26","current":-8.093505,"twenty":-3.607234,"median":-3.022611,"eighty":-2.532681,"marketCap":760449508},{"date":"2026-01-02","current":-7.554917,"twenty":-3.822008,"median":-3.080936,"eighty":-2.536797,"marketCap":709844883},{"date":"2026-01-09","current":-6.487534,"twenty":-5.801079,"median":-3.116551,"eighty":-2.545612,"marketCap":609555716},{"date":"2026-01-16","current":-7.197491,"twenty":-6.02239,"median":-3.152985,"eighty":-2.555745,"marketCap":676261813},{"date":"2026-01-23","current":-8.333421,"twenty":-6.159485,"median":-3.153012,"eighty":-2.557134,"marketCap":782991569},{"date":"2026-01-30","current":-7.530436,"twenty":-6.394505,"median":-3.1685,"eighty":-2.564099,"marketCap":707544672},{"date":"2026-02-06","current":-7.045707,"twenty":-6.577625,"median":-3.177319,"eighty":-2.571103,"marketCap":662000509},{"date":"2026-02-13","current":-7.251349,"twenty":-6.621691,"median":-3.225463,"eighty":-2.577189,"marketCap":681322276},{"date":"2026-02-20","current":-7.124047,"twenty":-6.808238,"median":-3.251382,"eighty":-2.579625,"marketCap":669361182},{"date":"2026-02-27","current":-7.128943,"twenty":-6.986952,"median":-3.264131,"eighty":-2.583458,"marketCap":669821224},{"date":"2026-03-06","current":-6.795998,"twenty":-6.986952,"median":-3.314482,"eighty":-2.597415,"marketCap":638538365},{"date":"2026-03-13","current":-5.364757,"twenty":-6.933093,"median":-3.361361,"eighty":-2.602624,"marketCap":683523737},{"date":"2026-03-20","current":-5.449912,"twenty":-6.913508,"median":-3.389716,"eighty":-2.60436,"marketCap":694373320},{"date":"2026-03-27","current":-5.399593,"twenty":-6.874338,"median":-3.399558,"eighty":-2.630404,"marketCap":687962203},{"date":"2026-04-02","current":-6.200823,"twenty":-6.843002,"median":-3.403031,"eighty":-2.640126,"marketCap":790046917},{"date":"2026-04-10","current":-7.056243,"twenty":-6.843002,"median":-3.432606,"eighty":-2.644683,"marketCap":899035912},{"date":"2026-04-17","current":-8.46904,"twenty":-6.943865,"median":-3.47248,"eighty":-2.645867,"marketCap":1079040359},{"date":"2026-04-24","current":-9.757975,"twenty":-7.080959,"median":-3.477689,"eighty":-2.64603,"marketCap":1243263595},{"date":"2026-05-01","current":-9.451524,"twenty":-7.125026,"median":-3.585277,"eighty":-2.656356,"marketCap":1204218641},{"date":"2026-05-08","current":-9.381799,"twenty":-7.197491,"median":-3.600715,"eighty":-2.670835,"marketCap":1195335061},{"date":"2026-05-15","current":-9.189592,"twenty":-7.279748,"median":-3.609293,"eighty":-2.676588,"marketCap":1191053783},{"date":"2026-05-22","current":-8.934431,"twenty":-7.436993,"median":-3.822008,"eighty":-2.684564,"marketCap":1157982667},{"date":"2026-05-29","current":-7.936639,"twenty":-7.480494,"median":-5.132517,"eighty":-2.691341,"marketCap":1028659795},{"date":"2026-06-05","current":-6.756045,"twenty":-7.480494,"median":-5.23899,"eighty":-2.696728,"marketCap":875644182},{"date":"2026-06-12","current":-7.36451,"twenty":-7.480494,"median":-5.370563,"eighty":-2.700201,"marketCap":954506790},{"date":"2026-06-18","current":-7.726324,"twenty":-7.487348,"median":-5.393787,"eighty":-2.710604,"marketCap":1001401091},{"date":"2026-06-26","current":-9.988804,"twenty":-7.591639,"median":-5.407335,"eighty":-2.731778,"marketCap":1294638873},{"date":"2026-07-02","current":-9.988804,"twenty":-7.673406,"median":-5.426688,"eighty":-2.743259,"marketCap":1294638873},{"date":"2026-07-10","current":-10.295658,"twenty":-7.795377,"median":-5.444106,"eighty":-2.744648,"marketCap":1334409990},{"date":"2026-07-17","current":-9.379675,"twenty":-7.921008,"median":-5.585386,"eighty":-2.752288,"marketCap":1215690240},{"date":"2026-07-24","current":-8.985802,"twenty":-8.046029,"median":-5.655171,"eighty":-2.766178,"marketCap":1164640747},{"date":"2026-07-31","current":-9.159838,"twenty":-8.108193,"median":-5.875502,"eighty":-2.788402,"marketCap":1187197500},{"date":"2026-08-07","current":-10.18574,"twenty":-8.267967,"median":-5.948946,"eighty":-2.798819,"marketCap":1320163620},{"date":"2026-08-14","current":-9.881583,"twenty":-8.338317,"median":-6.086042,"eighty":-2.805764,"marketCap":1514253784},{"date":"2026-08-21","current":-8.810836,"twenty":-8.64582,"median":-6.164381,"eighty":-2.819654,"marketCap":1350172526},{"date":"2026-08-28","current":-8.835737,"twenty":-8.844495,"median":-6.229853,"eighty":-2.840774,"marketCap":1353988369},{"date":"2026-09-04","current":-8.238111,"twenty":-8.852338,"median":-6.276995,"eighty":-2.844205,"marketCap":1262408131},{"date":"2026-09-11","current":-7.943448,"twenty":-8.846064,"median":-6.423883,"eighty":-2.855122,"marketCap":1217253987},{"date":"2026-09-18","current":-7.113412,"twenty":-8.837489,"median":-6.471481,"eighty":-2.857913,"marketCap":1090059213},{"date":"2026-09-25","current":-6.113218,"twenty":-8.815816,"median":-6.487254,"eighty":-2.866667,"marketCap":936789510},{"date":"2026-10-02","current":-5.7148,"twenty":-8.778603,"median":-6.436123,"eighty":-2.876875,"marketCap":875736018},{"date":"2026-10-09","current":-5.872507,"twenty":-8.733055,"median":-6.276995,"eighty":-2.889581,"marketCap":899903026}],"updateTime":1791844957241},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JBIO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1161050632","title":"Jade Biosciences:Jade301在灵长类动物中展现约25天半衰期及可预测的肌肉分布","url":"https://stock-news.laohu8.com/highlight/detail?id=1161050632","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161050632?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 19:03","pubTimestamp":1790766188,"startTime":"0","endTime":"0","summary":"Jade Biosciences公司宣布,Jade301在灵长类动物实验中表现出约25天的半衰期,同时其肌肉分布特征呈现出可预测性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186206760","title":"Jade Biosciences:Jade301展现高亲和力、选择性IFN-β结合能力,效力优于Dazukibart","url":"https://stock-news.laohu8.com/highlight/detail?id=1186206760","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186206760?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 19:03","pubTimestamp":1790766188,"startTime":"0","endTime":"0","summary":"Jade Biosciences宣布,Jade301在实验中展现出对IFN-β的高亲和力与选择性结合特性,且其效力超越Dazukibart。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160446327","title":"Jade Biosciences在EADV 2026公布Jade301临床前数据,一款潜在同类最佳的半衰期延长型抗IFN-β单克隆抗体用于皮肌炎治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1160446327","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160446327?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 19:01","pubTimestamp":1790766068,"startTime":"0","endTime":"0","summary":"Jade Biosciences在EADV 2026公布Jade301临床前数据,一款潜在同类最佳的半衰期延长型抗IFN-β单克隆抗体用于皮肌炎治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927621","title":"美国研究综述-卡迪纳尔健康、卢门图姆控股、公共仓储","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927621","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658927621?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 16:08","pubTimestamp":1786522123,"startTime":"0","endTime":"0","summary":"美国研究综述-卡迪纳尔健康、卢门图姆控股、公共仓储路透8月12日-周三,华尔街证券分析师调整了多家在美国上市公司的评级和目标股价,其中包括卡迪纳尔健康、卢门图姆控股和公共仓储。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4S4490GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG","LITE","NEMG","PNW","CVS","URBN","WELL","MIDD","CUBE","NTRA","TGT","UMAC","AMBQ","ACM","BCAX","LPTH","HLIO","ACVA","BBIO","CAVA","FLUT","MDLN","PSA","VTR","CRCL","NEM","MRCY","JAZZ","GAP","EXR","MAA","LEGN","CANC","LBRX","RPD","SR","CRWV","LENZ","MNST","ANF","CAH","HD","EGGY","JBIO","REIT","USFD","BLCK","LOW","SGMT","COAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119067640","title":"Jade Biosciences 与 Paragon Therapeutics 达成全球独家授权协议 - 美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1119067640","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119067640?lang=zh_cn&edition=fundamental","pubTime":"2026-07-07 16:44","pubTimestamp":1783413872,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件,Jade Biosciences公司已与Paragon Therapeutics签署了一项全球独家授权协议。\n根据协议条款,Jade Biosciences将向Paragon支付最高可达2200万美元的里程碑款项。此外,Jade Biosciences还需就授权产品的净销售额,向Paragon支付低至中个位数百分比的销售分成。\n该协议还包含一项为期至少五年的限制性条款,在此期间,Paragon被禁止针对协议授权的靶点发起新的研发活动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126834994","title":"Jade Biosciences - 美国证监会文件披露,Paragon被禁止针对许可靶点开展新项目至少五年","url":"https://stock-news.laohu8.com/highlight/detail?id=1126834994","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126834994?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 05:10","pubTimestamp":1782940247,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会(SEC)的文件,Jade Biosciences的合作方Paragon已被禁止在未来至少五年内,针对其获得许可的特定靶点发起任何新的研发或商业活动。\n这一限制性条款意味着,在规定的期限内,Paragon不得启动任何旨在开发或商业化针对该许可靶点的新项目或宣传活动。文件明确了这一禁令的持续时间,为公司的未来业务方向设定了明确的界限。\n此份监管文件的披露,为市场提供了关于Jade Biosciences与其合作伙伴之间权利划分的最新信息,可能对相关方的战略规划产生重要影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172380379","title":"Jade Biosciences与Paragon达成协议:按授权产品净销售额支付低至中个位数百分比特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1172380379","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172380379?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 05:10","pubTimestamp":1782940247,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会(SEC)的文件,Jade Biosciences 已与Paragon公司达成一项特许权使用费协议。根据该协议,Jade Biosciences 将就其授权产品的净销售额,向Paragon支付低至中个位数百分比范围的特许权使用费。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","JBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163004292","title":"Jade Biosciences 与 Paragon Therapeutics 签署全球独家许可协议 - SEC 文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1163004292","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163004292?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 05:09","pubTimestamp":1782940151,"startTime":"0","endTime":"0","summary":"Jade Biosciences 已与 Paragon Therapeutics 达成一项全球独家许可协议,相关细节已通过美国证券交易委员会(SEC)的文件正式披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102837563","title":"新闻稿:Jade Biosciences宣布任命Mark Eisner医学博士、公共卫生硕士加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1102837563","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102837563?lang=zh_cn&edition=fundamental","pubTime":"2026-06-26 19:02","pubTimestamp":1782471732,"startTime":"0","endTime":"0","summary":"旧金山与不列颠哥伦比亚省温哥华,2026年6月26日——专注于开发自身免疫性疾病领域最佳疗法的临床阶段生物技术公司Jade Biosciences, Inc.今日宣布,任命Mark Eisner医学博士、公共卫生硕士加入其董事会,自2026年6月25日起生效。Jade不承担也不接受任何公开更新或修订任何前瞻性陈述的义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640184045","title":"热门话题-Jade Biosciences因计划中的股权融资而股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2640184045","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640184045?lang=zh_cn&edition=fundamental","pubTime":"2026-06-04 05:10","pubTimestamp":1780521030,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nL4S42B1WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","JBIO","BK4139","BK4127","JEF","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163210976","title":"Jade Biosciences宣布首例受试者接受Jade201首次人体I期临床试验给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1163210976","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163210976?lang=zh_cn&edition=fundamental","pubTime":"2026-05-27 04:06","pubTimestamp":1779825979,"startTime":"0","endTime":"0","summary":"Jade Biosciences宣布,其新型半衰期延长的无岩藻糖基化抗Baff受体单克隆抗体Jade201,已为首例受试者完成首次人体I期临床试验的首次给药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125164700","title":"Jade Biosciences宣布首位受试者接受Jade101治疗IgA肾病的二期Juniper临床试验给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1125164700","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125164700?lang=zh_cn&edition=fundamental","pubTime":"2026-05-26 19:02","pubTimestamp":1779793349,"startTime":"0","endTime":"0","summary":"Jade Biosciences宣布,其针对IgA肾病的候选药物Jade101,在二期Juniper临床试验中已为首位受试者完成给药。这一进展标志着该药物临床开发的重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634403179","title":"美国研究综述-爱彼迎、HII、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2634403179","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634403179?lang=zh_cn&edition=fundamental","pubTime":"2026-05-11 15:29","pubTimestamp":1778484590,"startTime":"0","endTime":"0","summary":"美国研究综述-爱彼迎、HII、特斯拉路透5月11日 - 周一,华尔街证券分析师下调了多家美国上市公司的评级和目标股价,其中包括爱彼迎、HII和特斯拉。股票条目按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL4T41O0H2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","AMPH","ATLC","LEA","DASH","AMD","FRDU","GM","ESE","BAM","ABNB","HWM","ABNG","BWA","LNTH","CAR","F","JBIO","AVTX","HTZ","INTU","AZTA","CWH","ALB","DAMD","AMDY","AMDW","BCAX","AMDS","AGL","GT","ARXS","FERG","LOAR","AMYY","THRM","DAN","AMUU","ANIP","HII","BILL","IBP","HUBS","CVS","FRDD","FIS","GFS","TECH","GNTX","AMDG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137369906","title":"Jade Biosciences注册声明:售股股东拟转售最多3954.2339万股普通股——美国证监会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1137369906","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137369906?lang=zh_cn&edition=fundamental","pubTime":"2026-05-08 05:22","pubTimestamp":1778188934,"startTime":"0","endTime":"0","summary":"根据最新向美国证券交易委员会(SEC)提交的文件显示,生物科技公司Jade Biosciences(股票代码:JBIO)已提交注册声明,该声明涉及售股股东计划转售的普通股股份。\n文件表明,此次注册声明涵盖的普通股数量最高可达39,542,339股。这些股份将由公司指定的售股股东进行二级市场转售操作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151902012","title":"玉生物科学任命爱德华·R·康纳博士为首席医疗官","url":"https://stock-news.laohu8.com/highlight/detail?id=1151902012","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151902012?lang=zh_cn&edition=fundamental","pubTime":"2026-04-22 19:05","pubTimestamp":1776855940,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司玉生物科学今日宣布,任命医学博士爱德华·R·康纳为公司首席医疗官,此项任命自即日起生效。康纳博士在加入玉生物科学之前,曾任职于Ardelyx公司,担任首席医疗官。玉生物科学是一家临床阶段的生物技术公司,专注于开发针对自身免疫性疾病关键未满足需求的同类最佳疗法。公司的领先候选药物JADE101靶向细胞因子APRIL,目前正在评估用于治疗免疫球蛋白A肾病。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","R","BK4232","BK4022","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}